The Evaluation on The Pattern of Complementary Alternative Treatment Used by Cancer Patients

Mochamad Djunaedi, Wahyu Utami, Anila Impian Sukorini

Abstract

Objective: Complementary alternative treatment used among cancer patients is expected to support the therapeutic goal achievement. This study aims to evaluate the attitudes of cancer patients in an attempting to the treatment of cancer using the complementary alternative medicines (CAM) and to identify the CAM used by cancer patients. Methods: A cross-sectional study was conducted in 2016 using a “semi-structured questionnaire” in 100 respondents. Only 75 respondents were eligible and met the inclusion criteria. Results: The recommendations for using the CAM we found from non health professionals (85%). The used of CAM without prior assessments was 77%. Patients used CAM when the condition of the cancer had severe (87%). Conclusion: Integration of health personnel, including pharmacists to assist the team in using herbs, supplements or traditional medicine has not been done optimally.

Download


Paper Citation


in Harvard Style

Djunaedi M., Utami W. and Sukorini A. (2018). The Evaluation on The Pattern of Complementary Alternative Treatment Used by Cancer Patients.In Proceedings of BROMO Conference - Volume 1: BROMO, ISBN 978-989-758-347-6, pages 240-244. DOI: 10.5220/0008360602400244


in Bibtex Style

@conference{bromo18,
author={Mochamad Djunaedi and Wahyu Utami and Anila Impian Sukorini},
title={The Evaluation on The Pattern of Complementary Alternative Treatment Used by Cancer Patients},
booktitle={Proceedings of BROMO Conference - Volume 1: BROMO,},
year={2018},
pages={240-244},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0008360602400244},
isbn={978-989-758-347-6},
}


in EndNote Style

TY - CONF

JO - Proceedings of BROMO Conference - Volume 1: BROMO,
TI - The Evaluation on The Pattern of Complementary Alternative Treatment Used by Cancer Patients
SN - 978-989-758-347-6
AU - Djunaedi M.
AU - Utami W.
AU - Sukorini A.
PY - 2018
SP - 240
EP - 244
DO - 10.5220/0008360602400244